Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1280
Selected: 0
NCT IDTitle
NCT06450171Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
NCT02770014Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer
NCT03747419Avelumab and Radiation in Muscle-Invasive Bladder Cancer
NCT01961128RPFNA Assessment of Exercise Effect in Breast Cancer
NCT06117709Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
NCT00165230Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors
NCT01978899Healthy Living After Cancer: Weight Management Pilot Study
NCT00438256Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer
NCT05011279Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)
NCT00130702Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
NCT00165477Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00003045Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
NCT02285439Study of MEK162 for Children With Low-Grade Gliomas
NCT00496665ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
NCT00402545C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT02268851A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL
NCT01965353A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma
NCT02950766NeoVax Plus Ipilimumab in Renal Cell Carcinoma
NCT00215202Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
NCT00585637Vitamin D for Chemoprevention
NCT02268175Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
NCT03097328Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
NCT03773666A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
NCT00782626Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
NCT02489617The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
NCT04115059Dasatinib In Waldenström Macroglobulinemia
NCT01829217Sunitinib in Never-Smokers With Lung Adenocarcinoma
NCT02823262A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
NCT00165256Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
NCT01164956Methylphenidate for Cancer-Related Fatigue
NCT06523868Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
NCT07147023Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication
NCT05587439Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
NCT03130439Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
NCT03344965Olaparib In Metastatic Breast Cancer
NCT02766465Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
NCT00165334Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
NCT00516165RAD001 in Advanced Hepatocellular Carcinoma
NCT00003058Troglitazone in Treating Patients With Liposarcoma
NCT02880319Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
NCT03936465Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
NCT05629065Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
NCT01465334Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
NCT06414434BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
NCT01325506Effectiveness of Open and Robotic Prostatectomy
NCT03075072Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
NCT04150965Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
NCT03060720Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
NCT00601120RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma
NCT01841983Project A: Integrated Approaches to Improving the Health and Safety of Health Care Workers